Need Help? Call Us At (925) 400-9986
Contact Us at info@anchormolecular.com
NIPT
cfDNA contains Trisomy 13, 18 and 21 gDNA mixed with female gDNA at 2.5%, 5%, 7.5%, and 10% spiked in DNA-depleted human plasma. Used for counting-based assay, such as PerkinElmer’s Vanadis®.
This true human plasma-based, nucleosomally fragmented cfDNA product is designed for counting-based NIPT assays. The composition of the cfDNA contains XO (Turner Syndrome), XYY (Jacobs Syndrome), XXY (Klinefelter Syndrome) or XXX (Triple X Syndrome) at 10% fetal fraction.